fanta.bio Sample: CNhs11985
- Species
- human
- CRE Type
- ELA
- Cluster
- 1
- Cell Type Class
- Cardiovascular
28492 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| IRF3 SRX11453858 | Hep G2 Liver | 381 / 18533 (2.1%) | 58 / 185330 (0.0%) | −324.0 | −324.0 | 65.69 |
| TP53 SRX19538273 | U2OS Bone | 448 / 18533 (2.4%) | 126 / 185330 (0.1%) | −324.0 | −324.0 | 35.56 |
| TP53 SRX19538274 | U2OS Bone | 519 / 18533 (2.8%) | 147 / 185330 (0.1%) | −324.0 | −324.0 | 35.31 |
| TP53 SRX19538267 | U2OS Bone | 462 / 18533 (2.5%) | 132 / 185330 (0.1%) | −324.0 | −324.0 | 35.00 |
| TP53 SRX19538268 | U2OS Bone | 525 / 18533 (2.8%) | 150 / 185330 (0.1%) | −324.0 | −324.0 | 35.00 |
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1355 / 18533 (7.3%) | 410 / 185330 (0.2%) | −324.0 | −324.0 | 33.05 |
| TP53 SRX19538276 | U2OS Bone | 511 / 18533 (2.8%) | 156 / 185330 (0.1%) | −324.0 | −324.0 | 32.76 |
| TP53 SRX19538275 | U2OS Bone | 462 / 18533 (2.5%) | 142 / 185330 (0.1%) | −324.0 | −324.0 | 32.54 |
| HIF1A SRX11007095 | HK-2 Kidney | 2595 / 18533 (14.0%) | 907 / 185330 (0.5%) | −324.0 | −324.0 | 28.61 |
| TP53 SRX19538280 | Osteoblasts Bone | 503 / 18533 (2.7%) | 185 / 185330 (0.1%) | −324.0 | −324.0 | 27.19 |
| TP53 SRX19538279 | Osteoblasts Bone | 635 / 18533 (3.4%) | 246 / 185330 (0.1%) | −324.0 | −324.0 | 25.81 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1954 / 18533 (10.5%) | 759 / 185330 (0.4%) | −324.0 | −324.0 | 25.74 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 512 / 18533 (2.8%) | 200 / 185330 (0.1%) | −324.0 | −324.0 | 25.60 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1951 / 18533 (10.5%) | 786 / 185330 (0.4%) | −324.0 | −324.0 | 24.82 |
| SCML2 SRX644728 | 293 Kidney | 1700 / 18533 (9.2%) | 717 / 185330 (0.4%) | −324.0 | −324.0 | 23.71 |
| HIF1A SRX20663235 | HK-2 Kidney | 603 / 18533 (3.3%) | 258 / 185330 (0.1%) | −324.0 | −324.0 | 23.37 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2718 / 18533 (14.7%) | 1167 / 185330 (0.6%) | −324.0 | −324.0 | 23.29 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2638 / 18533 (14.2%) | 1150 / 185330 (0.6%) | −324.0 | −324.0 | 22.94 |
| TP53 SRX19538281 | Osteoblasts Bone | 537 / 18533 (2.9%) | 278 / 185330 (0.2%) | −324.0 | −324.0 | 19.32 |
| FOXP1 SRX736067 | LNCAP Prostate | 2109 / 18533 (11.4%) | 1147 / 185330 (0.6%) | −324.0 | −324.0 | 18.39 |
| MYH11 SRX265221 | ME-1 Blood | 938 / 18533 (5.1%) | 638 / 185330 (0.3%) | −324.0 | −324.0 | 14.70 |
| MED1 SRX9419945 | BT-474 Breast | 3896 / 18533 (21.0%) | 2955 / 185330 (1.6%) | −324.0 | −324.0 | 13.18 |
| BRD4 SRX9419935 | BT-474 Breast | 3918 / 18533 (21.1%) | 2973 / 185330 (1.6%) | −324.0 | −324.0 | 13.18 |
| MED1 SRX9419944 | BT-474 Breast | 3802 / 18533 (20.5%) | 2918 / 185330 (1.6%) | −324.0 | −324.0 | 13.03 |
| BRD4 SRX9419937 | BT-474 Breast | 3874 / 18533 (20.9%) | 2994 / 185330 (1.6%) | −324.0 | −324.0 | 12.94 |
| BRD4 SRX9419936 | BT-474 Breast | 3974 / 18533 (21.4%) | 3095 / 185330 (1.7%) | −324.0 | −324.0 | 12.84 |
| MED1 SRX9419946 | BT-474 Breast | 3975 / 18533 (21.4%) | 3121 / 185330 (1.7%) | −324.0 | −324.0 | 12.74 |
| BRD4 SRX9419938 | BT-474 Breast | 3920 / 18533 (21.2%) | 3109 / 185330 (1.7%) | −324.0 | −324.0 | 12.61 |
| MED1 SRX9419947 | BT-474 Breast | 3824 / 18533 (20.6%) | 3085 / 185330 (1.7%) | −324.0 | −324.0 | 12.40 |
| EZH2 SRX2146136 | LNCAP Prostate | 8591 / 18533 (46.4%) | 8677 / 185330 (4.7%) | −324.0 | −324.0 | 9.90 |
| BRD4 SRX736201 | 90-8TL Neural | 6691 / 18533 (36.1%) | 7054 / 185330 (3.8%) | −324.0 | −324.0 | 9.49 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 807 / 18533 (4.4%) | 953 / 185330 (0.5%) | −324.0 | −324.0 | 8.47 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 778 / 18533 (4.2%) | 1024 / 185330 (0.6%) | −324.0 | −324.0 | 7.60 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 2060 / 18533 (11.1%) | 2904 / 185330 (1.6%) | −324.0 | −324.0 | 7.09 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1592 / 18533 (8.6%) | 3991 / 185330 (2.2%) | −324.0 | −324.0 | 3.99 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1795 / 18533 (9.7%) | 5494 / 185330 (3.0%) | −324.0 | −324.0 | 3.27 |
| PBX4 SRX2731658 | PC-3 Prostate | 1047 / 18533 (5.6%) | 29154 / 185330 (15.7%) | −324.0 | −324.0 | 0.36 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 743 / 18533 (4.0%) | 964 / 185330 (0.5%) | −312.2 | −309.3 | 7.71 |
| AGO2 SRX4708039 | Hep G2 Liver | 2162 / 18533 (11.7%) | 8181 / 185330 (4.4%) | −309.6 | −306.7 | 2.64 |
| TP53 SRX19538269 | U2OS Bone | 558 / 18533 (3.0%) | 432 / 185330 (0.2%) | −308.9 | −305.9 | 12.92 |
| 8-Hydroxydeoxyguanosine SRX6895233 | MCF 10A Breast | 1153 / 18533 (6.2%) | 2726 / 185330 (1.5%) | −298.7 | −295.8 | 4.23 |
| 8-Hydroxydeoxyguanosine SRX2935293 | MCF 10A Breast | 804 / 18533 (4.3%) | 1287 / 185330 (0.7%) | −292.2 | −289.3 | 6.25 |
| 8-Hydroxydeoxyguanosine SRX6895232 | MCF 10A Breast | 1199 / 18533 (6.5%) | 3016 / 185330 (1.6%) | −291.0 | −288.1 | 3.98 |
| KAT6A SRX20971022 | Fibroblasts Others | 326 / 18533 (1.8%) | 49 / 185330 (0.0%) | −280.7 | −277.8 | 66.53 |
| TP53 SRX19538270 | U2OS Bone | 523 / 18533 (2.8%) | 437 / 185330 (0.2%) | −279.4 | −276.6 | 11.97 |
| FOS SRX150477 | MCF 10A Breast | 742 / 18533 (4.0%) | 21643 / 185330 (11.7%) | −279.0 | −276.1 | 0.34 |
| AR SRX10820653 | LNCAP Prostate | 413 / 18533 (2.2%) | 188 / 185330 (0.1%) | −278.8 | −276.0 | 21.97 |
| IRF3 SRX11453861 | Hep G2 Liver | 333 / 18533 (1.8%) | 62 / 185330 (0.0%) | −277.2 | −274.4 | 53.71 |
| FOS SRX150478 | MCF 10A Breast | 787 / 18533 (4.2%) | 22213 / 185330 (12.0%) | −275.1 | −272.2 | 0.35 |
| FOXA1 SRX4815198 | MCF-7 Breast | 1102 / 18533 (5.9%) | 26638 / 185330 (14.4%) | −268.2 | −265.4 | 0.41 |
| TP53 SRX19538282 | Osteoblasts Bone | 454 / 18533 (2.4%) | 301 / 185330 (0.2%) | −268.2 | −265.4 | 15.08 |
| 8-Hydroxydeoxyguanosine SRX6895234 | MCF 10A Breast | 1078 / 18533 (5.8%) | 2668 / 185330 (1.4%) | −265.6 | −262.8 | 4.04 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 717 / 18533 (3.9%) | 20585 / 185330 (11.1%) | −258.9 | −256.1 | 0.35 |
| YAP1 SRX757325 | H2052 Lung | 849 / 18533 (4.6%) | 22515 / 185330 (12.1%) | −256.4 | −253.6 | 0.38 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 574 / 18533 (3.1%) | 699 / 185330 (0.4%) | −250.5 | −247.7 | 8.21 |
| Epitope tags SRX10549776 | K-562 Blood | 1598 / 18533 (8.6%) | 5682 / 185330 (3.1%) | −249.1 | −246.3 | 2.81 |
| FOXA1 SRX4815197 | MCF-7 Breast | 817 / 18533 (4.4%) | 21768 / 185330 (11.7%) | −248.8 | −246.1 | 0.38 |
| 5-mC SRX882970 | LNCAP Prostate | 3209 / 18533 (17.3%) | 16714 / 185330 (9.0%) | −244.4 | −241.6 | 1.92 |
| DTL SRX4107934 | U2OS Bone | 1433 / 18533 (7.7%) | 4813 / 185330 (2.6%) | −242.3 | −239.6 | 2.98 |
| SKP2 SRX4107930 | HCT 116 Digestive tract | 1418 / 18533 (7.7%) | 4772 / 185330 (2.6%) | −239.1 | −236.3 | 2.97 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 572 / 18533 (3.1%) | 761 / 185330 (0.4%) | −236.0 | −233.3 | 7.52 |
| ESR1 SRX7624157 | MCF-7 Breast | 913 / 18533 (4.9%) | 22657 / 185330 (12.2%) | −233.8 | −231.1 | 0.40 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 320 / 18533 (1.7%) | 111 / 185330 (0.1%) | −233.4 | −230.7 | 28.83 |
| 8-Hydroxydeoxyguanosine SRX13840520 | MCF 10A Breast | 1077 / 18533 (5.8%) | 2985 / 185330 (1.6%) | −233.2 | −230.5 | 3.61 |
| SKP2 SRX4107932 | HCT 116 Digestive tract | 1515 / 18533 (8.2%) | 5429 / 185330 (2.9%) | −232.7 | −230.0 | 2.79 |
| FOXA1 SRX176862 | MCF-7 Breast | 441 / 18533 (2.4%) | 15246 / 185330 (8.2%) | −232.1 | −229.4 | 0.29 |
| 5-mC SRX882968 | LNCAP Prostate | 3149 / 18533 (17.0%) | 16614 / 185330 (9.0%) | −231.2 | −228.5 | 1.90 |
| FOS SRX4192880 | MCF 10A Breast | 586 / 18533 (3.2%) | 17592 / 185330 (9.5%) | −231.1 | −228.4 | 0.33 |
| TP53 SRX19538271 | U2OS Bone | 718 / 18533 (3.9%) | 1336 / 185330 (0.7%) | −231.1 | −228.4 | 5.37 |
| YAP1 SRX757326 | H2052 Lung | 750 / 18533 (4.0%) | 20131 / 185330 (10.9%) | −230.9 | −228.3 | 0.37 |
| KAT7 SRX101303 | RKO Digestive tract | 1533 / 18533 (8.3%) | 5567 / 185330 (3.0%) | −230.6 | −227.9 | 2.75 |
| AR SRX10820651 | LNCAP Prostate | 416 / 18533 (2.2%) | 321 / 185330 (0.2%) | −230.4 | −227.7 | 12.96 |
| MCM2 SRX12221314 | HCT 116 Digestive tract | 546 / 18533 (2.9%) | 713 / 185330 (0.4%) | −228.0 | −225.3 | 7.66 |
| RUNX1 SRX2513054 | 293 Kidney | 3511 / 18533 (18.9%) | 19473 / 185330 (10.5%) | −227.3 | −224.6 | 1.80 |
| BMI1 SRX644729 | 293 Kidney | 313 / 18533 (1.7%) | 113 / 185330 (0.1%) | −225.9 | −223.3 | 27.70 |
| BRD1 SRX286203 | RKO Digestive tract | 1331 / 18533 (7.2%) | 4486 / 185330 (2.4%) | −223.4 | −220.8 | 2.97 |
| FOXA1 SRX176863 | MCF-7 Breast | 414 / 18533 (2.2%) | 14492 / 185330 (7.8%) | −222.7 | −220.1 | 0.29 |
| TP53 SRX396254 | Fibroblasts Others | 1042 / 18533 (5.6%) | 2921 / 185330 (1.6%) | −222.4 | −219.8 | 3.57 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 250 / 18533 (1.3%) | 11461 / 185330 (6.2%) | −219.7 | −217.1 | 0.22 |
| ESR1 SRX4367193 | MCF-7 Breast | 1195 / 18533 (6.4%) | 26069 / 185330 (14.1%) | −218.3 | −215.7 | 0.46 |
| BRPF3 SRX796085 | RKO Digestive tract | 1205 / 18533 (6.5%) | 3871 / 185330 (2.1%) | −216.0 | −213.4 | 3.11 |
| AR SRX1067071 | LHSAR Prostate | 720 / 18533 (3.9%) | 19148 / 185330 (10.3%) | −215.9 | −213.3 | 0.38 |
| FOXA1 SRX3931044 | MCF-7 Breast | 786 / 18533 (4.2%) | 20132 / 185330 (10.9%) | −215.8 | −213.2 | 0.39 |
| AGO2 SRX6783957 | Hep G2 Liver | 1384 / 18533 (7.5%) | 4908 / 185330 (2.6%) | −215.4 | −212.8 | 2.82 |
| ESR1 SRX371478 | MCF-7 Breast | 469 / 18533 (2.5%) | 15165 / 185330 (8.2%) | −215.1 | −212.5 | 0.31 |
| MCM2 SRX12221319 | HCT 116 Digestive tract | 515 / 18533 (2.8%) | 678 / 185330 (0.4%) | −213.8 | −211.2 | 7.60 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2251 / 18533 (12.1%) | 10588 / 185330 (5.7%) | −212.0 | −209.4 | 2.13 |
| 5-mC SRX882965 | LNCAP Prostate | 2576 / 18533 (13.9%) | 12910 / 185330 (7.0%) | −211.3 | −208.7 | 2.00 |
| BRD4 SRX736204 | 90-8TL Neural | 1059 / 18533 (5.7%) | 3141 / 185330 (1.7%) | −210.7 | −208.1 | 3.37 |
| ESR1 SRX371469 | MCF-7 Breast | 375 / 18533 (2.0%) | 13424 / 185330 (7.2%) | −210.2 | −207.6 | 0.28 |
| FOXA1 SRX1161177 | MCF-7 Breast | 362 / 18533 (2.0%) | 13152 / 185330 (7.1%) | −208.6 | −206.0 | 0.28 |
| JUNB SRX8488088 | SUM 229PE Breast | 721 / 18533 (3.9%) | 18893 / 185330 (10.2%) | −208.4 | −205.8 | 0.38 |
| ESR1 SRX7624156 | MCF-7 Breast | 595 / 18533 (3.2%) | 16950 / 185330 (9.1%) | −208.0 | −205.5 | 0.35 |
| ESR1 SRX20282961 | MCF-7 Breast | 470 / 18533 (2.5%) | 14936 / 185330 (8.1%) | −207.6 | −205.1 | 0.31 |
| FOXA1 SRX371481 | MCF-7 Breast | 385 / 18533 (2.1%) | 13474 / 185330 (7.3%) | −206.3 | −203.7 | 0.29 |
| AR SRX1067070 | LHSAR Prostate | 931 / 18533 (5.0%) | 21884 / 185330 (11.8%) | −205.9 | −203.3 | 0.43 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 908 / 18533 (4.9%) | 2427 / 185330 (1.3%) | −204.5 | −202.0 | 3.74 |
| AGO2 SRX6783958 | Hep G2 Liver | 1341 / 18533 (7.2%) | 4861 / 185330 (2.6%) | −201.3 | −198.8 | 2.76 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1508 / 18533 (8.1%) | 5881 / 185330 (3.2%) | −201.2 | −198.6 | 2.56 |
| GATA3 SRX190239 | MCF-7 Breast | 564 / 18533 (3.0%) | 16214 / 185330 (8.7%) | −200.8 | −198.3 | 0.35 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 443 / 18533 (2.4%) | 14258 / 185330 (7.7%) | −200.4 | −197.9 | 0.31 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 653 / 18533 (3.5%) | 17573 / 185330 (9.5%) | −200.2 | −197.6 | 0.37 |
| 5-hmC SRX19636323 | HMLE Breast | 1593 / 18533 (8.6%) | 6446 / 185330 (3.5%) | −199.4 | −196.9 | 2.47 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 440 / 18533 (2.4%) | 14172 / 185330 (7.6%) | −199.3 | −196.8 | 0.31 |
| BRPF3 SRX796086 | RKO Digestive tract | 1587 / 18533 (8.6%) | 6413 / 185330 (3.5%) | −199.1 | −196.6 | 2.47 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 542 / 18533 (2.9%) | 15804 / 185330 (8.5%) | −198.9 | −196.4 | 0.34 |
| BRPF3 SRX796084 | RKO Digestive tract | 1641 / 18533 (8.9%) | 6767 / 185330 (3.7%) | −198.6 | −196.1 | 2.42 |
| TLE3 SRX4815191 | MCF-7 Breast | 361 / 18533 (1.9%) | 12804 / 185330 (6.9%) | −198.2 | −195.7 | 0.28 |
| FOXA1 SRX371483 | MCF-7 Breast | 431 / 18533 (2.3%) | 13981 / 185330 (7.5%) | −198.1 | −195.6 | 0.31 |
| 8-Hydroxydeoxyguanosine SRX13840522 | MCF 10A Breast | 1372 / 18533 (7.4%) | 5100 / 185330 (2.8%) | −197.9 | −195.4 | 2.69 |
| FOS SRX150517 | MCF 10A Breast | 660 / 18533 (3.6%) | 17596 / 185330 (9.5%) | −197.8 | −195.4 | 0.38 |
| STAT5B SRX831881 | CD8+ T cells Blood | 293 / 18533 (1.6%) | 134 / 185330 (0.1%) | −197.5 | −195.0 | 21.87 |
| FOXA1 SRX371482 | MCF-7 Breast | 556 / 18533 (3.0%) | 15974 / 185330 (8.6%) | −197.5 | −195.0 | 0.35 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 696 / 18533 (3.8%) | 1503 / 185330 (0.8%) | −195.8 | −193.3 | 4.63 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 705 / 18533 (3.8%) | 1550 / 185330 (0.8%) | −194.9 | −192.4 | 4.55 |
| ESR1 SRX371476 | MCF-7 Breast | 274 / 18533 (1.5%) | 11143 / 185330 (6.0%) | −194.3 | −191.9 | 0.25 |
| FOS SRX150476 | MCF 10A Breast | 676 / 18533 (3.6%) | 17634 / 185330 (9.5%) | −192.2 | −189.8 | 0.38 |
| ESR1 SRX371471 | ZR-75-1 Breast | 421 / 18533 (2.3%) | 13612 / 185330 (7.3%) | −191.9 | −189.4 | 0.31 |
| ESR1 SRX176860 | MCF-7 Breast | 650 / 18533 (3.5%) | 17148 / 185330 (9.3%) | −189.6 | −187.1 | 0.38 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 858 / 18533 (4.6%) | 20188 / 185330 (10.9%) | −188.9 | −186.5 | 0.43 |
| ESR1 SRX371470 | ZR-75-1 Breast | 354 / 18533 (1.9%) | 12370 / 185330 (6.7%) | −188.4 | −186.0 | 0.29 |
| SSRP1 SRX3436567 | HT-1080 Bone | 453 / 18533 (2.4%) | 595 / 185330 (0.3%) | −188.3 | −185.9 | 7.61 |
| NFYB SRX16608147 | HeLa Uterus | 303 / 18533 (1.6%) | 177 / 185330 (0.1%) | −187.9 | −185.5 | 17.12 |
| ING5 SRX286202 | RKO Digestive tract | 1435 / 18533 (7.7%) | 5658 / 185330 (3.1%) | −187.3 | −184.9 | 2.54 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 265 / 18533 (1.4%) | 104 / 185330 (0.1%) | −187.0 | −184.6 | 25.48 |
| ESR1 SRX371479 | MCF-7 Breast | 368 / 18533 (2.0%) | 12562 / 185330 (6.8%) | −187.0 | −184.5 | 0.29 |
| FOXA1 SRX1161176 | MCF-7 Breast | 375 / 18533 (2.0%) | 12664 / 185330 (6.8%) | −186.5 | −184.0 | 0.30 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 498 / 18533 (2.7%) | 14654 / 185330 (7.9%) | −185.8 | −183.4 | 0.34 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 581 / 18533 (3.1%) | 15926 / 185330 (8.6%) | −185.0 | −182.6 | 0.36 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 1331 / 18533 (7.2%) | 26542 / 185330 (14.3%) | −185.0 | −182.6 | 0.50 |
| ESR1 SRX371467 | MCF-7 Breast | 415 / 18533 (2.2%) | 13268 / 185330 (7.2%) | −184.5 | −182.1 | 0.31 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 2062 / 18533 (11.1%) | 9896 / 185330 (5.3%) | −184.3 | −181.9 | 2.08 |
| FOXA1 SRX100454 | T-47D Breast | 510 / 18533 (2.8%) | 14781 / 185330 (8.0%) | −184.0 | −181.6 | 0.35 |
| ESR1 SRX20282960 | MCF-7 Breast | 464 / 18533 (2.5%) | 14041 / 185330 (7.6%) | −183.6 | −181.3 | 0.33 |
| FOXA1 SRX1161173 | MCF-7 Breast | 310 / 18533 (1.7%) | 11422 / 185330 (6.2%) | −182.5 | −180.1 | 0.27 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 381 / 18533 (2.1%) | 12605 / 185330 (6.8%) | −181.6 | −179.2 | 0.30 |
| 8-Hydroxydeoxyguanosine SRX2935292 | MCF 10A Breast | 1803 / 18533 (9.7%) | 8187 / 185330 (4.4%) | −180.8 | −178.4 | 2.20 |
| CIC SRX13262055 | Astrocytes Neural | 3188 / 18533 (17.2%) | 18382 / 185330 (9.9%) | −180.7 | −178.3 | 1.73 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 518 / 18533 (2.8%) | 14779 / 185330 (8.0%) | −180.3 | −177.9 | 0.35 |
| CEBPB SRX150632 | HeLa Uterus | 919 / 18533 (5.0%) | 20716 / 185330 (11.2%) | −180.2 | −177.8 | 0.44 |
| BrdU SRX3758833 | HeLa Uterus | 575 / 18533 (3.1%) | 1102 / 185330 (0.6%) | −180.1 | −177.7 | 5.22 |
| ESR1 SRX371468 | MCF-7 Breast | 250 / 18533 (1.3%) | 10256 / 185330 (5.5%) | −179.5 | −177.2 | 0.24 |
| ESR1 SRX176861 | MCF-7 Breast | 673 / 18533 (3.6%) | 17122 / 185330 (9.2%) | −179.4 | −177.1 | 0.39 |
| 5-hmC SRX19636322 | HMLE Breast | 1855 / 18533 (10.0%) | 8571 / 185330 (4.6%) | −179.3 | −177.0 | 2.16 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 531 / 18533 (2.9%) | 14927 / 185330 (8.1%) | −178.7 | −176.3 | 0.36 |
| FOXA1 SRX371480 | MCF-7 Breast | 263 / 18533 (1.4%) | 10454 / 185330 (5.6%) | −178.4 | −176.1 | 0.25 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 358 / 18533 (1.9%) | 12067 / 185330 (6.5%) | −176.9 | −174.6 | 0.30 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1228 / 18533 (6.6%) | 4567 / 185330 (2.5%) | −176.2 | −173.9 | 2.69 |
| YAP1 SRX5718140 | 293 Kidney | 698 / 18533 (3.8%) | 17350 / 185330 (9.4%) | −175.5 | −173.2 | 0.40 |
| TP53 SRX19538272 | U2OS Bone | 600 / 18533 (3.2%) | 1242 / 185330 (0.7%) | −175.4 | −173.1 | 4.83 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 1353 / 18533 (7.3%) | 26390 / 185330 (14.2%) | −174.7 | −172.4 | 0.51 |
| ESR1 SRX20282939 | MCF-7 Breast | 477 / 18533 (2.6%) | 13933 / 185330 (7.5%) | −174.5 | −172.2 | 0.34 |
| CUL4A SRX4107936 | U2OS Bone | 1485 / 18533 (8.0%) | 6213 / 185330 (3.4%) | −174.1 | −171.8 | 2.39 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 371 / 18533 (2.0%) | 12179 / 185330 (6.6%) | −173.7 | −171.4 | 0.30 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 316 / 18533 (1.7%) | 11243 / 185330 (6.1%) | −173.7 | −171.3 | 0.28 |
| FOXA1 SRX1161175 | MCF-7 Breast | 303 / 18533 (1.6%) | 11017 / 185330 (5.9%) | −173.6 | −171.3 | 0.28 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 409 / 18533 (2.2%) | 12766 / 185330 (6.9%) | −172.4 | −170.1 | 0.32 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1479 / 18533 (8.0%) | 27918 / 185330 (15.1%) | −172.1 | −169.8 | 0.53 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 1092 / 18533 (5.9%) | 22759 / 185330 (12.3%) | −171.5 | −169.2 | 0.48 |
| ESR1 SRX194569 | MCF-7 Breast | 439 / 18533 (2.4%) | 13197 / 185330 (7.1%) | −170.8 | −168.5 | 0.33 |
| ESR1 SRX371477 | MCF-7 Breast | 190 / 18533 (1.0%) | 8851 / 185330 (4.8%) | −170.4 | −168.1 | 0.21 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 546 / 18533 (2.9%) | 1055 / 185330 (0.6%) | −169.8 | −167.4 | 5.18 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 723 / 18533 (3.9%) | 17482 / 185330 (9.4%) | −169.4 | −167.1 | 0.41 |
| ESR1 SRX20282954 | MCF-7 Breast | 466 / 18533 (2.5%) | 13542 / 185330 (7.3%) | −168.3 | −166.0 | 0.34 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 1243 / 18533 (6.7%) | 24651 / 185330 (13.3%) | −168.2 | −165.9 | 0.50 |
| ESR1 SRX1531791 | MCF-7 Breast | 416 / 18533 (2.2%) | 12737 / 185330 (6.9%) | −168.1 | −165.8 | 0.33 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 384 / 18533 (2.1%) | 12212 / 185330 (6.6%) | −168.1 | −165.8 | 0.31 |
| FOS SRX4192879 | MCF 10A Breast | 486 / 18533 (2.6%) | 13843 / 185330 (7.5%) | −167.8 | −165.5 | 0.35 |
| ESR1 SRX194572 | MCF-7 Breast | 266 / 18533 (1.4%) | 10170 / 185330 (5.5%) | −167.4 | −165.1 | 0.26 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 689 / 18533 (3.7%) | 16896 / 185330 (9.1%) | −167.0 | −164.8 | 0.41 |
| CDK9 SRX7366783 | MCF-7 Breast | 267 / 18533 (1.4%) | 153 / 185330 (0.1%) | −166.8 | −164.5 | 17.45 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 894 / 18533 (4.8%) | 19811 / 185330 (10.7%) | −166.4 | −164.1 | 0.45 |
| AR SRX1067066 | LHSAR Prostate | 882 / 18533 (4.8%) | 19638 / 185330 (10.6%) | −166.2 | −163.9 | 0.45 |
| FOXA1 SRX1161174 | MCF-7 Breast | 438 / 18533 (2.4%) | 13013 / 185330 (7.0%) | −165.9 | −163.6 | 0.34 |
| MEAF6 DRX234811 | 293 Kidney | 1765 / 18533 (9.5%) | 8261 / 185330 (4.5%) | −165.4 | −163.2 | 2.14 |
| GATA3 SRX190194 | SK-N-SH Neural | 993 / 18533 (5.4%) | 21139 / 185330 (11.4%) | −165.1 | −162.9 | 0.47 |
| LEO1 SRX1873456 | SEM Blood | 1533 / 18533 (8.3%) | 6705 / 185330 (3.6%) | −164.9 | −162.6 | 2.29 |
| MCM2 SRX10644253 | HCT 116 Digestive tract | 391 / 18533 (2.1%) | 505 / 185330 (0.3%) | −164.3 | −162.0 | 7.74 |
| FOXA1 SRX11222437 | MCF-7 Breast | 295 / 18533 (1.6%) | 10565 / 185330 (5.7%) | −163.8 | −161.6 | 0.28 |
| GATA3 SRX176864 | MCF-7 Breast | 316 / 18533 (1.7%) | 10922 / 185330 (5.9%) | −163.7 | −161.5 | 0.29 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1792 / 18533 (9.7%) | 8508 / 185330 (4.6%) | −162.8 | −160.5 | 2.11 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 297 / 18533 (1.6%) | 10564 / 185330 (5.7%) | −162.8 | −160.5 | 0.28 |
| FOXA1 SRX11222442 | MCF-7 Breast | 273 / 18533 (1.5%) | 10130 / 185330 (5.5%) | −162.2 | −160.0 | 0.27 |
| FOXA2 SRX3230382 | Hep G2 Liver | 584 / 18533 (3.2%) | 15149 / 185330 (8.2%) | −162.2 | −159.9 | 0.39 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 444 / 18533 (2.4%) | 12981 / 185330 (7.0%) | −162.1 | −159.9 | 0.34 |
| FOXA1 SRX11222441 | MCF-7 Breast | 322 / 18533 (1.7%) | 10975 / 185330 (5.9%) | −162.1 | −159.9 | 0.29 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 460 / 18533 (2.5%) | 13233 / 185330 (7.1%) | −162.1 | −159.8 | 0.35 |
| AR SRX1067067 | LHSAR Prostate | 722 / 18533 (3.9%) | 17187 / 185330 (9.3%) | −162.1 | −159.8 | 0.42 |
| TCF12 SRX190356 | SK-N-SH Neural | 1156 / 18533 (6.2%) | 23208 / 185330 (12.5%) | −161.7 | −159.5 | 0.50 |
| MEAF6 DRX300417 | 293 Kidney | 1611 / 18533 (8.7%) | 7299 / 185330 (3.9%) | −161.4 | −159.1 | 2.21 |
| ESR1 SRX371475 | BT-474 Breast | 205 / 18533 (1.1%) | 8858 / 185330 (4.8%) | −161.1 | −158.9 | 0.23 |
| ESR1 SRX20282972 | MCF-7 Breast | 492 / 18533 (2.7%) | 13693 / 185330 (7.4%) | −160.9 | −158.6 | 0.36 |
| SMARCA4 SRX5212362 | Mel270 Others | 746 / 18533 (4.0%) | 17489 / 185330 (9.4%) | −160.8 | −158.6 | 0.43 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 931 / 18533 (5.0%) | 3058 / 185330 (1.7%) | −160.7 | −158.5 | 3.04 |
| JUN SRX17561461 | LPS141 Adipocyte | 632 / 18533 (3.4%) | 15810 / 185330 (8.5%) | −160.6 | −158.4 | 0.40 |
| MCM3 SRX9107922 | hTERT RPE-1 Neural | 353 / 18533 (1.9%) | 401 / 185330 (0.2%) | −160.4 | −158.2 | 8.80 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1620 / 18533 (8.7%) | 29190 / 185330 (15.8%) | −160.4 | −158.1 | 0.55 |
| 5-mC SRX518254 | MCF-7 Breast | 778 / 18533 (4.2%) | 2247 / 185330 (1.2%) | −159.2 | −157.0 | 3.46 |
| MethylCap SRX014766 | NB-4 Blood | 1672 / 18533 (9.0%) | 7764 / 185330 (4.2%) | −159.0 | −156.8 | 2.15 |
| TRP47 SRX4548329 | THP-1 Blood | 2701 / 18533 (14.6%) | 15302 / 185330 (8.3%) | −158.7 | −156.4 | 1.77 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 1346 / 18533 (7.3%) | 25578 / 185330 (13.8%) | −158.5 | −156.3 | 0.53 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 568 / 18533 (3.1%) | 1238 / 185330 (0.7%) | −158.1 | −155.9 | 4.59 |
| ESR1 SRX2943591 | MCF-7 Breast | 301 / 18533 (1.6%) | 10481 / 185330 (5.7%) | −158.0 | −155.8 | 0.29 |
| CDK9 SRX7366781 | MCF-7 Breast | 251 / 18533 (1.4%) | 141 / 185330 (0.1%) | −158.0 | −155.8 | 17.80 |
| AR SRX9469988 | LAPC-4 Prostate | 573 / 18533 (3.1%) | 14820 / 185330 (8.0%) | −157.8 | −155.5 | 0.39 |
| SMARCA2 SRX8119677 | MeT-5A Others | 707 / 18533 (3.8%) | 16791 / 185330 (9.1%) | −157.4 | −155.2 | 0.42 |
| ESR1 SRX20282973 | MCF-7 Breast | 531 / 18533 (2.9%) | 14169 / 185330 (7.6%) | −157.4 | −155.2 | 0.37 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 344 / 18533 (1.9%) | 11188 / 185330 (6.0%) | −157.4 | −155.2 | 0.31 |
| FOXA1 SRX3923514 | MCF-7 Breast | 443 / 18533 (2.4%) | 12784 / 185330 (6.9%) | −157.0 | −154.8 | 0.35 |
| IRF4 SRX8602206 | OCI-LY-10 Blood | 356 / 18533 (1.9%) | 427 / 185330 (0.2%) | −156.6 | −154.4 | 8.34 |
| ESR1 SRX4367192 | MCF-7 Breast | 884 / 18533 (4.8%) | 19264 / 185330 (10.4%) | −156.3 | −154.1 | 0.46 |
| Epitope tags DRX443510 | 293 Kidney | 1511 / 18533 (8.2%) | 6737 / 185330 (3.6%) | −156.1 | −153.9 | 2.24 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 839 / 18533 (4.5%) | 18620 / 185330 (10.0%) | −156.0 | −153.8 | 0.45 |
| ESR1 SRX20282940 | MCF-7 Breast | 485 / 18533 (2.6%) | 13400 / 185330 (7.2%) | −155.8 | −153.6 | 0.36 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 411 / 18533 (2.2%) | 12206 / 185330 (6.6%) | −155.1 | −152.9 | 0.34 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 383 / 18533 (2.1%) | 11749 / 185330 (6.3%) | −155.0 | −152.8 | 0.33 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 1037 / 18533 (5.6%) | 21308 / 185330 (11.5%) | −154.9 | −152.7 | 0.49 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 404 / 18533 (2.2%) | 12083 / 185330 (6.5%) | −154.8 | −152.7 | 0.33 |
| ESR1 SRX20282955 | MCF-7 Breast | 476 / 18533 (2.6%) | 13215 / 185330 (7.1%) | −154.6 | −152.4 | 0.36 |
| STAT3 SRX2020842 | HCC70 Breast | 781 / 18533 (4.2%) | 17728 / 185330 (9.6%) | −154.2 | −152.0 | 0.44 |
| MITF SRX1555436 | 501A Epidermis | 2026 / 18533 (10.9%) | 10379 / 185330 (5.6%) | −154.1 | −152.0 | 1.95 |
| TEAD1 SRX3401272 | MCF-7 Breast | 335 / 18533 (1.8%) | 10918 / 185330 (5.9%) | −153.8 | −151.7 | 0.31 |
| Epitope tags SRX392692 | T3M-1 Cl-10 Others | 215 / 18533 (1.2%) | 81 / 185330 (0.0%) | −153.5 | −151.4 | 26.54 |
| FOXA1 SRX3931043 | MCF-7 Breast | 446 / 18533 (2.4%) | 12710 / 185330 (6.9%) | −153.5 | −151.3 | 0.35 |
| DNMT3B SRX2862487 | hESC HUES8 Pluripotent stem cell | 307 / 18533 (1.7%) | 294 / 185330 (0.2%) | −153.3 | −151.1 | 10.44 |
| SMARCA4 SRX5212366 | Mel270 Others | 601 / 18533 (3.2%) | 15069 / 185330 (8.1%) | −153.2 | −151.0 | 0.40 |
| MethylCap SRX014767 | NB-4 Blood | 1807 / 18533 (9.8%) | 8841 / 185330 (4.8%) | −153.0 | −150.9 | 2.04 |
| ESR1 SRX371474 | BT-474 Breast | 197 / 18533 (1.1%) | 8458 / 185330 (4.6%) | −152.8 | −150.6 | 0.23 |
| JUNB SRX8488073 | SUM 229PE Breast | 829 / 18533 (4.5%) | 18349 / 185330 (9.9%) | −152.7 | −150.6 | 0.45 |
| Epitope tags SRX10549778 | K-562 Blood | 1151 / 18533 (6.2%) | 4484 / 185330 (2.4%) | −152.3 | −150.2 | 2.57 |
| GATA3 SRX5057632 | MCF-7 Breast | 296 / 18533 (1.6%) | 10207 / 185330 (5.5%) | −152.2 | −150.1 | 0.29 |
| RAC1 SRX10365541 | MCF-7 Breast | 240 / 18533 (1.3%) | 9227 / 185330 (5.0%) | −152.2 | −150.0 | 0.26 |
| SMARCA4 SRX5212357 | Mel270 Others | 644 / 18533 (3.5%) | 15667 / 185330 (8.5%) | −152.2 | −150.0 | 0.41 |
| NR2F2 SRX190293 | MCF-7 Breast | 469 / 18533 (2.5%) | 13016 / 185330 (7.0%) | −152.1 | −149.9 | 0.36 |
| SSRP1 SRX3436564 | HT-1080 Bone | 561 / 18533 (3.0%) | 1261 / 185330 (0.7%) | −151.5 | −149.3 | 4.45 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 404 / 18533 (2.2%) | 11966 / 185330 (6.5%) | −151.5 | −149.3 | 0.34 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 419 / 18533 (2.3%) | 12199 / 185330 (6.6%) | −151.2 | −149.1 | 0.34 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 1055 / 18533 (5.7%) | 21395 / 185330 (11.5%) | −151.2 | −149.0 | 0.49 |
| ARID1A SRX5089376 | MCF-7 Breast | 399 / 18533 (2.2%) | 11872 / 185330 (6.4%) | −151.0 | −148.8 | 0.34 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 429 / 18533 (2.3%) | 12335 / 185330 (6.7%) | −150.5 | −148.3 | 0.35 |
| FOXA1 SRX100506 | Hep G2 Liver | 598 / 18533 (3.2%) | 14914 / 185330 (8.0%) | −150.2 | −148.1 | 0.40 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 1029 / 18533 (5.6%) | 20997 / 185330 (11.3%) | −150.2 | −148.0 | 0.49 |
| MCM2 SRX12221312 | HCT 116 Digestive tract | 365 / 18533 (2.0%) | 488 / 185330 (0.3%) | −150.0 | −147.8 | 7.48 |
| NKX2-1 SRX2164786 | A549 Lung | 740 / 18533 (4.0%) | 16965 / 185330 (9.2%) | −149.7 | −147.6 | 0.44 |
| JUN SRX4192884 | MCF 10A Breast | 378 / 18533 (2.0%) | 11488 / 185330 (6.2%) | −149.7 | −147.6 | 0.33 |
| MCM2 SRX12221308 | HCT 116 Digestive tract | 366 / 18533 (2.0%) | 495 / 185330 (0.3%) | −149.2 | −147.1 | 7.39 |
| JUNB SRX10119386 | MCF 10A Breast | 409 / 18533 (2.2%) | 11967 / 185330 (6.5%) | −149.1 | −147.0 | 0.34 |
| ESR1 SRX10365535 | MCF-7 Breast | 372 / 18533 (2.0%) | 11345 / 185330 (6.1%) | −148.4 | −146.3 | 0.33 |
| 5-mC SRX518261 | MCF 10A Breast | 441 / 18533 (2.4%) | 778 / 185330 (0.4%) | −148.0 | −145.8 | 5.67 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 864 / 18533 (4.7%) | 18618 / 185330 (10.0%) | −147.4 | −145.2 | 0.46 |
| TLE3 SRX4815192 | MCF-7 Breast | 412 / 18533 (2.2%) | 11954 / 185330 (6.5%) | −147.4 | −145.2 | 0.34 |
| YBX1 SRX2424527 | MCF-7 Breast | 299 / 18533 (1.6%) | 294 / 185330 (0.2%) | −147.3 | −145.1 | 10.17 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 324 / 18533 (1.7%) | 10513 / 185330 (5.7%) | −147.1 | −145.0 | 0.31 |
| ESR1 SRX10365536 | MCF-7 Breast | 245 / 18533 (1.3%) | 9156 / 185330 (4.9%) | −147.1 | −145.0 | 0.27 |
| VGLL1 SRX24602130 | BT-20 Breast | 478 / 18533 (2.6%) | 12973 / 185330 (7.0%) | −147.0 | −144.9 | 0.37 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 873 / 18533 (4.7%) | 18716 / 185330 (10.1%) | −146.8 | −144.7 | 0.47 |
| ARID1A SRX5089379 | MCF-7 Breast | 458 / 18533 (2.5%) | 12658 / 185330 (6.8%) | −146.7 | −144.6 | 0.36 |
| FOXA1 SRX3931055 | MCF-7 Breast | 383 / 18533 (2.1%) | 11465 / 185330 (6.2%) | −146.6 | −144.5 | 0.33 |
| JUNB SRX8488089 | SUM 229PE Breast | 461 / 18533 (2.5%) | 12696 / 185330 (6.9%) | −146.6 | −144.5 | 0.36 |
| FOXA2 SRX100448 | Hep G2 Liver | 505 / 18533 (2.7%) | 13378 / 185330 (7.2%) | −146.6 | −144.5 | 0.38 |
| SSRP1 SRX3436566 | HT-1080 Bone | 330 / 18533 (1.8%) | 390 / 185330 (0.2%) | −146.5 | −144.4 | 8.46 |
| ESR1 SRX2881002 | MCF-7 Breast | 437 / 18533 (2.4%) | 12309 / 185330 (6.6%) | −146.2 | −144.1 | 0.36 |
| FOXA1 SRX1787653 | MCF-7 Breast | 375 / 18533 (2.0%) | 11320 / 185330 (6.1%) | −146.2 | −144.1 | 0.33 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 423 / 18533 (2.3%) | 12081 / 185330 (6.5%) | −146.1 | −144.0 | 0.35 |
| SMARCA4 SRX5212371 | Mel270 Others | 647 / 18533 (3.5%) | 15474 / 185330 (8.3%) | −146.0 | −143.9 | 0.42 |
| SOX13 SRX2636248 | Hep G2 Liver | 626 / 18533 (3.4%) | 15160 / 185330 (8.2%) | −145.9 | −143.8 | 0.41 |
| MCM2 SRX12221321 | HCT 116 Digestive tract | 332 / 18533 (1.8%) | 401 / 185330 (0.2%) | −145.5 | −143.4 | 8.28 |
| JUNB SRX4192882 | MCF 10A Breast | 366 / 18533 (2.0%) | 11129 / 185330 (6.0%) | −145.0 | −142.9 | 0.33 |
| RAC1 SRX10365543 | MCF-7 Breast | 251 / 18533 (1.4%) | 9186 / 185330 (5.0%) | −144.8 | −142.7 | 0.27 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 220 / 18533 (1.2%) | 8628 / 185330 (4.7%) | −144.6 | −142.5 | 0.25 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 416 / 18533 (2.2%) | 11913 / 185330 (6.4%) | −144.4 | −142.3 | 0.35 |
| Epitope tags SRX392691 | T3M-1 Cl-10 Others | 217 / 18533 (1.2%) | 104 / 185330 (0.1%) | −144.2 | −142.2 | 20.87 |
| ARID5B SRX3230377 | Hep G2 Liver | 1124 / 18533 (6.1%) | 22005 / 185330 (11.9%) | −144.0 | −142.0 | 0.51 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 578 / 18533 (3.1%) | 14370 / 185330 (7.8%) | −143.8 | −141.7 | 0.40 |
| ESR1 SRX10365532 | MCF-7 Breast | 252 / 18533 (1.4%) | 9170 / 185330 (4.9%) | −143.8 | −141.7 | 0.27 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 438 / 18533 (2.4%) | 12233 / 185330 (6.6%) | −143.7 | −141.6 | 0.36 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 1263 / 18533 (6.8%) | 23784 / 185330 (12.8%) | −142.9 | −140.8 | 0.53 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 778 / 18533 (4.2%) | 2441 / 185330 (1.3%) | −142.9 | −140.8 | 3.19 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 442 / 18533 (2.4%) | 12265 / 185330 (6.6%) | −142.8 | −140.7 | 0.36 |
| NR3C1 SRX17639412 | A549 Lung | 511 / 18533 (2.8%) | 13320 / 185330 (7.2%) | −142.6 | −140.5 | 0.38 |
| FOXA1 SRX3931054 | MCF-7 Breast | 433 / 18533 (2.3%) | 12111 / 185330 (6.5%) | −142.5 | −140.4 | 0.36 |
| ESR1 SRX2881000 | MCF-7 Breast | 414 / 18533 (2.2%) | 11811 / 185330 (6.4%) | −142.4 | −140.3 | 0.35 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 504 / 18533 (2.7%) | 13199 / 185330 (7.1%) | −142.2 | −140.2 | 0.38 |
| FOXA1 SRX1961158 | T-47D Breast | 454 / 18533 (2.4%) | 12418 / 185330 (6.7%) | −141.9 | −139.8 | 0.37 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 673 / 18533 (3.6%) | 1896 / 185330 (1.0%) | −141.8 | −139.8 | 3.55 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 649 / 18533 (3.5%) | 15319 / 185330 (8.3%) | −141.3 | −139.2 | 0.42 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 812 / 18533 (4.4%) | 2650 / 185330 (1.4%) | −141.1 | −139.1 | 3.06 |
| FOXA1 SRX1161203 | T-47D Breast | 330 / 18533 (1.8%) | 10407 / 185330 (5.6%) | −141.1 | −139.0 | 0.32 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 436 / 18533 (2.4%) | 12100 / 185330 (6.5%) | −140.8 | −138.7 | 0.36 |
| ESR1 SRX5323873 | MCF-7 Breast | 572 / 18533 (3.1%) | 14164 / 185330 (7.6%) | −140.7 | −138.6 | 0.40 |
| CEBPA SRX2630241 | Hep G2 Liver | 570 / 18533 (3.1%) | 14122 / 185330 (7.6%) | −140.4 | −138.4 | 0.40 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 1572 / 18533 (8.5%) | 27611 / 185330 (14.9%) | −140.2 | −138.1 | 0.57 |
| ESR1 SRX20282946 | MCF-7 Breast | 287 / 18533 (1.5%) | 9655 / 185330 (5.2%) | −140.1 | −138.1 | 0.30 |
| FOXA1 SRX11222438 | MCF-7 Breast | 249 / 18533 (1.3%) | 8996 / 185330 (4.9%) | −140.0 | −138.0 | 0.28 |
| SREBF2 SRX5359048 | HCC70 Breast | 1698 / 18533 (9.2%) | 8387 / 185330 (4.5%) | −140.0 | −137.9 | 2.02 |
| NANOG SRX10445309 | Neural crest cells Neural | 256 / 18533 (1.4%) | 9110 / 185330 (4.9%) | −139.7 | −137.7 | 0.28 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 421 / 18533 (2.3%) | 11814 / 185330 (6.4%) | −139.5 | −137.4 | 0.36 |
| GATAD2A SRX2636506 | Hep G2 Liver | 603 / 18533 (3.3%) | 14575 / 185330 (7.9%) | −139.4 | −137.4 | 0.41 |
| ESR1 SRX4451213 | MCF-7 Breast | 476 / 18533 (2.6%) | 12669 / 185330 (6.8%) | −139.4 | −137.4 | 0.38 |
| BrdU SRX3758835 | HeLa Uterus | 252 / 18533 (1.4%) | 197 / 185330 (0.1%) | −138.9 | −136.8 | 12.79 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 737 / 18533 (4.0%) | 2274 / 185330 (1.2%) | −138.3 | −136.3 | 3.24 |
| FOXA1 SRX1961157 | T-47D Breast | 507 / 18533 (2.7%) | 13098 / 185330 (7.1%) | −138.3 | −136.3 | 0.39 |
| ESR1 SRX330067 | MCF-7 Breast | 434 / 18533 (2.3%) | 11975 / 185330 (6.5%) | −138.3 | −136.3 | 0.36 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 679 / 18533 (3.7%) | 15628 / 185330 (8.4%) | −138.2 | −136.1 | 0.43 |
| GATA3 SRX6712581 | MCF-7 Breast | 388 / 18533 (2.1%) | 11245 / 185330 (6.1%) | −138.1 | −136.1 | 0.35 |
| SS18 SRX3468047 | Fibroblasts Others | 1143 / 18533 (6.2%) | 21979 / 185330 (11.9%) | −137.9 | −135.9 | 0.52 |
| JUN SRX883584 | MDA-MB-231 Breast | 737 / 18533 (4.0%) | 16445 / 185330 (8.9%) | −137.9 | −135.8 | 0.45 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 387 / 18533 (2.1%) | 11203 / 185330 (6.0%) | −137.3 | −135.3 | 0.35 |
| HIRA SRX502812 | IMR-90 Lung | 355 / 18533 (1.9%) | 519 / 185330 (0.3%) | −137.3 | −135.2 | 6.84 |
| RELA SRX5938177 | FaDu Others | 437 / 18533 (2.4%) | 11987 / 185330 (6.5%) | −137.3 | −135.2 | 0.36 |
| ESR1 SRX20282971 | MCF-7 Breast | 475 / 18533 (2.6%) | 12570 / 185330 (6.8%) | −137.2 | −135.2 | 0.38 |
| FOXA1 SRX3923516 | MCF-7 Breast | 339 / 18533 (1.8%) | 10422 / 185330 (5.6%) | −137.2 | −135.2 | 0.33 |
| 8-Hydroxydeoxyguanosine SRX13840523 | MCF 10A Breast | 1791 / 18533 (9.7%) | 9129 / 185330 (4.9%) | −137.0 | −134.9 | 1.96 |
| FOXA1 SRX5323843 | MCF-7 Breast | 247 / 18533 (1.3%) | 8857 / 185330 (4.8%) | −136.8 | −134.8 | 0.28 |
| JUNB SRX8488074 | SUM 229PE Breast | 633 / 18533 (3.4%) | 14912 / 185330 (8.0%) | −136.8 | −134.8 | 0.42 |
| ARID5B SRX10475139 | Hep G2 Liver | 519 / 18533 (2.8%) | 13222 / 185330 (7.1%) | −136.8 | −134.8 | 0.39 |
| AR SRX9109110 | MDA-MB-453 Breast | 870 / 18533 (4.7%) | 18252 / 185330 (9.8%) | −136.7 | −134.7 | 0.48 |
| MCM2 SRX12221323 | HCT 116 Digestive tract | 590 / 18533 (3.2%) | 1533 / 185330 (0.8%) | −136.6 | −134.6 | 3.85 |
| FOXA1 SRX3923517 | MCF-7 Breast | 338 / 18533 (1.8%) | 10381 / 185330 (5.6%) | −136.5 | −134.5 | 0.33 |
| ESR1 SRX20282953 | MCF-7 Breast | 396 / 18533 (2.1%) | 11317 / 185330 (6.1%) | −136.5 | −134.5 | 0.35 |
| HIRA SRX502814 | IMR-90 Lung | 307 / 18533 (1.7%) | 363 / 185330 (0.2%) | −136.3 | −134.3 | 8.46 |
| SSRP1 SRX253232 | Fibrosarcoma Others | 268 / 18533 (1.4%) | 248 / 185330 (0.1%) | −136.2 | −134.2 | 10.81 |
| ESR1 SRX3110725 | MCF-7 Breast | 425 / 18533 (2.3%) | 11762 / 185330 (6.3%) | −136.2 | −134.2 | 0.36 |
| FOXA1 SRX5323829 | T-47D Breast | 263 / 18533 (1.4%) | 9113 / 185330 (4.9%) | −136.2 | −134.2 | 0.29 |
| GATAD2A SRX2636507 | Hep G2 Liver | 516 / 18533 (2.8%) | 13152 / 185330 (7.1%) | −136.1 | −134.1 | 0.39 |
| WWTR1 SRX10119367 | MCF 10A Breast | 555 / 18533 (3.0%) | 13731 / 185330 (7.4%) | −136.0 | −134.0 | 0.40 |
| FOXA1 SRX028634 | MCF-7 Breast | 237 / 18533 (1.3%) | 8652 / 185330 (4.7%) | −135.9 | −133.9 | 0.27 |
| FOXA1 SRX6878603 | LNCAP Prostate | 515 / 18533 (2.8%) | 13124 / 185330 (7.1%) | −135.7 | −133.7 | 0.39 |
| FOXA1 SRX1447317 | MCF-7 Breast | 310 / 18533 (1.7%) | 9888 / 185330 (5.3%) | −135.6 | −133.6 | 0.31 |
| FOXA1 SRX100477 | Hep G2 Liver | 544 / 18533 (2.9%) | 13547 / 185330 (7.3%) | −135.4 | −133.4 | 0.40 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 1304 / 18533 (7.0%) | 23956 / 185330 (12.9%) | −135.2 | −133.2 | 0.54 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 409 / 18533 (2.2%) | 11473 / 185330 (6.2%) | −135.1 | −133.1 | 0.36 |
| ETS1 SRX3033231 | HEYA8 Gonad | 306 / 18533 (1.7%) | 366 / 185330 (0.2%) | −134.9 | −132.9 | 8.36 |
| FOXA1 SRX1787652 | MCF-7 Breast | 295 / 18533 (1.6%) | 9610 / 185330 (5.2%) | −134.7 | −132.7 | 0.31 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 189 / 18533 (1.0%) | 7752 / 185330 (4.2%) | −134.7 | −132.7 | 0.24 |
| SSRP1 SRX3436563 | HT-1080 Bone | 870 / 18533 (4.7%) | 3078 / 185330 (1.7%) | −134.2 | −132.3 | 2.83 |
| FOXL2 SRX6957431 | KGN Gonad | 1055 / 18533 (5.7%) | 20642 / 185330 (11.1%) | −134.1 | −132.1 | 0.51 |
| ESR1 SRX330070 | MCF-7 Breast | 253 / 18533 (1.4%) | 8866 / 185330 (4.8%) | −133.9 | −131.9 | 0.29 |
| EP300 SRX176885 | MCF-7 Breast | 255 / 18533 (1.4%) | 8888 / 185330 (4.8%) | −133.5 | −131.5 | 0.29 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 814 / 18533 (4.4%) | 17338 / 185330 (9.4%) | −133.4 | −131.4 | 0.47 |
| EP300 SRX2194266 | SUM 159PT Breast | 818 / 18533 (4.4%) | 17392 / 185330 (9.4%) | −133.3 | −131.3 | 0.47 |
| AR SRX9109113 | MDA-MB-453 Breast | 901 / 18533 (4.9%) | 18530 / 185330 (10.0%) | −133.3 | −131.3 | 0.49 |
| SSRP1 SRX3436565 | HT-1080 Bone | 467 / 18533 (2.5%) | 992 / 185330 (0.5%) | −133.1 | −131.2 | 4.71 |
| FOXA1 SRX15430999 | T-47D Breast | 532 / 18533 (2.9%) | 13278 / 185330 (7.2%) | −133.1 | −131.1 | 0.40 |
| KAT7 DRX234808 | 293 Kidney | 773 / 18533 (4.2%) | 2537 / 185330 (1.4%) | −133.0 | −131.1 | 3.05 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 458 / 18533 (2.5%) | 12144 / 185330 (6.6%) | −132.7 | −130.7 | 0.38 |
| FOXA1 SRX028635 | MCF-7 Breast | 243 / 18533 (1.3%) | 8653 / 185330 (4.7%) | −132.6 | −130.6 | 0.28 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 617 / 18533 (3.3%) | 14509 / 185330 (7.8%) | −132.5 | −130.6 | 0.43 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 380 / 18533 (2.1%) | 10917 / 185330 (5.9%) | −132.5 | −130.5 | 0.35 |
| PGR SRX1012655 | MCF-7 Breast | 319 / 18533 (1.7%) | 9924 / 185330 (5.4%) | −132.2 | −130.3 | 0.32 |
| BrdU SRX3758834 | HeLa Uterus | 304 / 18533 (1.6%) | 372 / 185330 (0.2%) | −132.2 | −130.2 | 8.17 |
| JADE3 DRX300415 | 293 Kidney | 1518 / 18533 (8.2%) | 7312 / 185330 (3.9%) | −132.1 | −130.2 | 2.08 |
| BrdU SRX144720 | HeLa Uterus | 258 / 18533 (1.4%) | 236 / 185330 (0.1%) | −131.9 | −130.0 | 10.93 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 243 / 18533 (1.3%) | 8625 / 185330 (4.7%) | −131.8 | −129.8 | 0.28 |
| NANOG SRX5286326 | hESC WIBR2 Pluripotent stem cell | 408 / 18533 (2.2%) | 11320 / 185330 (6.1%) | −131.3 | −129.4 | 0.36 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 518 / 18533 (2.8%) | 12999 / 185330 (7.0%) | −131.3 | −129.3 | 0.40 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 314 / 18533 (1.7%) | 9807 / 185330 (5.3%) | −131.3 | −129.3 | 0.32 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 1058 / 18533 (5.7%) | 20543 / 185330 (11.1%) | −131.1 | −129.1 | 0.52 |
| FOXA1 SRX5323830 | T-47D Breast | 288 / 18533 (1.6%) | 9367 / 185330 (5.1%) | −131.0 | −129.1 | 0.31 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1552 / 18533 (8.4%) | 7578 / 185330 (4.1%) | −131.0 | −129.1 | 2.05 |
| FOXA1 SRX3923518 | MCF-7 Breast | 338 / 18533 (1.8%) | 10190 / 185330 (5.5%) | −131.0 | −129.0 | 0.33 |
| ESR1 SRX330069 | MCF-7 Breast | 307 / 18533 (1.7%) | 9682 / 185330 (5.2%) | −131.0 | −129.0 | 0.32 |
| ESR1 SRX5323871 | MCF-7 Breast | 532 / 18533 (2.9%) | 13182 / 185330 (7.1%) | −130.6 | −128.7 | 0.40 |
| MCM2 SRX12221347 | HCT 116 Digestive tract | 524 / 18533 (2.8%) | 1275 / 185330 (0.7%) | −130.4 | −128.4 | 4.11 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1800 / 18533 (9.7%) | 9370 / 185330 (5.1%) | −130.4 | −128.4 | 1.92 |
| MEAF6 SRX10606585 | GIST-T1 Digestive tract | 1715 / 18533 (9.3%) | 8754 / 185330 (4.7%) | −130.4 | −128.4 | 1.96 |
| ESR1 SRX8537722 | MCF-7 Breast | 457 / 18533 (2.5%) | 12040 / 185330 (6.5%) | −130.3 | −128.3 | 0.38 |
| ESR1 SRX20282938 | MCF-7 Breast | 399 / 18533 (2.2%) | 11135 / 185330 (6.0%) | −130.2 | −128.2 | 0.36 |
| ARID5B SRX10475138 | Hep G2 Liver | 800 / 18533 (4.3%) | 16998 / 185330 (9.2%) | −130.0 | −128.1 | 0.47 |
| BMI1 SRX7196721 | SF8628 Neural | 1704 / 18533 (9.2%) | 8689 / 185330 (4.7%) | −129.8 | −127.8 | 1.96 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 501 / 18533 (2.7%) | 12684 / 185330 (6.8%) | −129.8 | −127.8 | 0.39 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1613 / 18533 (8.7%) | 8044 / 185330 (4.3%) | −129.6 | −127.7 | 2.01 |
| ZEB1 SRX13298925 | MCF-7 Breast | 312 / 18533 (1.7%) | 9714 / 185330 (5.2%) | −129.5 | −127.6 | 0.32 |
| ARID1A SRX5089385 | MCF-7 Breast | 372 / 18533 (2.0%) | 10684 / 185330 (5.8%) | −129.5 | −127.5 | 0.35 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 567 / 18533 (3.1%) | 13657 / 185330 (7.4%) | −129.4 | −127.5 | 0.42 |
| EP300 SRX2194265 | SUM 159PT Breast | 757 / 18533 (4.1%) | 16366 / 185330 (8.8%) | −129.2 | −127.2 | 0.46 |
| ESR1 SRX4451212 | MCF-7 Breast | 466 / 18533 (2.5%) | 12132 / 185330 (6.5%) | −129.1 | −127.1 | 0.38 |
| STAT3 SRX150479 | MCF 10A Breast | 464 / 18533 (2.5%) | 12086 / 185330 (6.5%) | −128.7 | −126.7 | 0.38 |
| STAT3 SRX150630 | MCF 10A Breast | 460 / 18533 (2.5%) | 12024 / 185330 (6.5%) | −128.6 | −126.7 | 0.38 |
| ESR1 SRX1012632 | MCF-7 Breast | 250 / 18533 (1.3%) | 8640 / 185330 (4.7%) | −128.5 | −126.6 | 0.29 |
| PROX1 SRX3230397 | Hep G2 Liver | 363 / 18533 (2.0%) | 10494 / 185330 (5.7%) | −128.2 | −126.3 | 0.35 |
| JUNB SRX10119384 | MCF 10A Breast | 309 / 18533 (1.7%) | 9617 / 185330 (5.2%) | −128.1 | −126.1 | 0.32 |
| ESR1 SRX1012629 | MCF-7 Breast | 317 / 18533 (1.7%) | 9749 / 185330 (5.3%) | −128.1 | −126.1 | 0.33 |
| ESR1 SRX2943589 | MCF-7 Breast | 260 / 18533 (1.4%) | 8792 / 185330 (4.7%) | −128.0 | −126.1 | 0.30 |
| WWTR1 SRX10119378 | MCF 10A Breast | 531 / 18533 (2.9%) | 13069 / 185330 (7.1%) | −128.0 | −126.1 | 0.41 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 842 / 18533 (4.5%) | 17490 / 185330 (9.4%) | −128.0 | −126.0 | 0.48 |
| FOXA1 SRX9550898 | Prostate cancer Prostate | 344 / 18533 (1.9%) | 10174 / 185330 (5.5%) | −127.7 | −125.8 | 0.34 |
| RNF2 SRX18954719 | SCC-25 Others | 656 / 18533 (3.5%) | 14878 / 185330 (8.0%) | −127.7 | −125.8 | 0.44 |
| RNF2 SRX18954704 | FaDu Others | 1116 / 18533 (6.0%) | 21156 / 185330 (11.4%) | −127.7 | −125.8 | 0.53 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 423 / 18533 (2.3%) | 11418 / 185330 (6.2%) | −127.6 | −125.7 | 0.37 |
| SOX5 SRX2636544 | Hep G2 Liver | 497 / 18533 (2.7%) | 12543 / 185330 (6.8%) | −127.6 | −125.6 | 0.40 |
| ESR1 SRX10365558 | MCF-7 Breast | 344 / 18533 (1.9%) | 10169 / 185330 (5.5%) | −127.6 | −125.6 | 0.34 |
| SMARCA4 SRX027488 | hESC H9 Pluripotent stem cell | 146 / 18533 (0.8%) | 6723 / 185330 (3.6%) | −127.6 | −125.6 | 0.22 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 662 / 18533 (3.6%) | 14952 / 185330 (8.1%) | −127.5 | −125.6 | 0.44 |
| ESR1 SRX5323878 | MCF-7 Breast | 499 / 18533 (2.7%) | 12571 / 185330 (6.8%) | −127.5 | −125.5 | 0.40 |
| JUNB SRX10119383 | MCF 10A Breast | 352 / 18533 (1.9%) | 10285 / 185330 (5.5%) | −127.2 | −125.3 | 0.34 |
| FOXA1 SRX3931033 | MCF-7 Breast | 319 / 18533 (1.7%) | 9737 / 185330 (5.3%) | −126.8 | −124.9 | 0.33 |
| HMG20A SRX2630163 | Hep G2 Liver | 292 / 18533 (1.6%) | 9277 / 185330 (5.0%) | −126.4 | −124.5 | 0.31 |
| EP300 SRX150579 | HeLa Uterus | 341 / 18533 (1.8%) | 10081 / 185330 (5.4%) | −126.4 | −124.5 | 0.34 |
| FOS SRX3322636 | MCF-7 Breast | 336 / 18533 (1.8%) | 9995 / 185330 (5.4%) | −126.3 | −124.4 | 0.34 |
| ESR1 SRX5323872 | MCF-7 Breast | 498 / 18533 (2.7%) | 12506 / 185330 (6.7%) | −126.2 | −124.3 | 0.40 |
| FOXA1 SRX1787651 | MCF-7 Breast | 292 / 18533 (1.6%) | 9267 / 185330 (5.0%) | −126.1 | −124.2 | 0.32 |
| EP300 SRX1012648 | MCF-7 Breast | 244 / 18533 (1.3%) | 8455 / 185330 (4.6%) | −126.1 | −124.2 | 0.29 |
| SP1 SRX190358 | HCT 116 Digestive tract | 755 / 18533 (4.1%) | 16202 / 185330 (8.7%) | −126.0 | −124.1 | 0.47 |
| FOXA2 SRX10475773 | Hep G2 Liver | 602 / 18533 (3.2%) | 14024 / 185330 (7.6%) | −125.9 | −124.0 | 0.43 |
| Epitope tags SRX392690 | T3M-1 Cl-10 Others | 177 / 18533 (1.0%) | 68 / 185330 (0.0%) | −125.8 | −123.9 | 26.03 |
| FOXA1 SRX3923519 | MCF-7 Breast | 309 / 18533 (1.7%) | 9527 / 185330 (5.1%) | −125.5 | −123.6 | 0.32 |
| FOXA1 SRX9604647 | LNCAP Prostate | 725 / 18533 (3.9%) | 15761 / 185330 (8.5%) | −125.4 | −123.5 | 0.46 |
| NANOG SRX3288567 | hESC H9 Pluripotent stem cell | 188 / 18533 (1.0%) | 7442 / 185330 (4.0%) | −125.4 | −123.5 | 0.25 |
| JUND SRX150408 | HeLa Uterus | 450 / 18533 (2.4%) | 11742 / 185330 (6.3%) | −125.2 | −123.3 | 0.38 |
| FOXA1 SRX1787655 | MCF-7 Breast | 258 / 18533 (1.4%) | 8663 / 185330 (4.7%) | −125.1 | −123.2 | 0.30 |
| MCM3 SRX9107918 | hTERT RPE-1 Neural | 211 / 18533 (1.1%) | 139 / 185330 (0.1%) | −125.1 | −123.2 | 15.18 |
| ARID1A SRX5089382 | MCF-7 Breast | 363 / 18533 (2.0%) | 10376 / 185330 (5.6%) | −124.9 | −123.0 | 0.35 |
| ING2 SRX286201 | RKO Digestive tract | 1386 / 18533 (7.5%) | 6572 / 185330 (3.5%) | −124.6 | −122.7 | 2.11 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 382 / 18533 (2.1%) | 10667 / 185330 (5.8%) | −124.6 | −122.7 | 0.36 |
| ESR1 SRX1469949 | MCF-7 Breast | 296 / 18533 (1.6%) | 9283 / 185330 (5.0%) | −124.5 | −122.6 | 0.32 |
| MCM2 SRX12221346 | HCT 116 Digestive tract | 543 / 18533 (2.9%) | 1425 / 185330 (0.8%) | −124.3 | −122.4 | 3.81 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 669 / 18533 (3.6%) | 14924 / 185330 (8.1%) | −124.3 | −122.4 | 0.45 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1894 / 18533 (10.2%) | 10236 / 185330 (5.5%) | −124.1 | −122.2 | 1.85 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 345 / 18533 (1.9%) | 10057 / 185330 (5.4%) | −124.0 | −122.1 | 0.34 |
| GATA3 SRX100559 | T-47D Breast | 549 / 18533 (3.0%) | 13163 / 185330 (7.1%) | −123.7 | −121.8 | 0.42 |
| STAT1 SRX23678708 | K-562 Blood | 1504 / 18533 (8.1%) | 7420 / 185330 (4.0%) | −123.7 | −121.8 | 2.03 |
| ESR1 SRX3123829 | MCF-7 Breast | 300 / 18533 (1.6%) | 9315 / 185330 (5.0%) | −123.6 | −121.7 | 0.32 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 766 / 18533 (4.1%) | 16257 / 185330 (8.8%) | −123.6 | −121.7 | 0.47 |
| FOSL2 SRX190296 | SK-N-SH Neural | 663 / 18533 (3.6%) | 14802 / 185330 (8.0%) | −123.4 | −121.5 | 0.45 |
| RUNX1 SRX2014504 | Jurkat Blood | 2400 / 18533 (12.9%) | 14124 / 185330 (7.6%) | −123.3 | −121.4 | 1.70 |
| JADE3 DRX234809 | 293 Kidney | 1001 / 18533 (5.4%) | 4054 / 185330 (2.2%) | −123.2 | −121.3 | 2.47 |
| EP300 SRX100544 | Hep G2 Liver | 392 / 18533 (2.1%) | 10756 / 185330 (5.8%) | −122.8 | −120.9 | 0.36 |
| YAP1 SRX10119364 | MCF 10A Breast | 432 / 18533 (2.3%) | 11375 / 185330 (6.1%) | −122.7 | −120.8 | 0.38 |
| FOXA1 SRX190181 | A549 Lung | 367 / 18533 (2.0%) | 10350 / 185330 (5.6%) | −122.4 | −120.5 | 0.35 |
| Crotonyllysine SRX19488269 | GSC23 Neural | 1191 / 18533 (6.4%) | 5307 / 185330 (2.9%) | −122.1 | −120.2 | 2.24 |
| FOXA1 SRX3923515 | MCF-7 Breast | 288 / 18533 (1.6%) | 9066 / 185330 (4.9%) | −122.1 | −120.2 | 0.32 |
| DOT1L SRX10606581 | GIST-T1 Digestive tract | 2044 / 18533 (11.0%) | 11424 / 185330 (6.2%) | −122.0 | −120.2 | 1.79 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 344 / 18533 (1.9%) | 9973 / 185330 (5.4%) | −122.0 | −120.1 | 0.34 |
| FOSL2 SRX190204 | A549 Lung | 505 / 18533 (2.7%) | 12447 / 185330 (6.7%) | −122.0 | −120.1 | 0.41 |
| PBX3 SRX190343 | SK-N-SH Neural | 1004 / 18533 (5.4%) | 19407 / 185330 (10.5%) | −121.9 | −120.0 | 0.52 |
| TFAP2C SRX018833 | MCF-7 Breast | 464 / 18533 (2.5%) | 11818 / 185330 (6.4%) | −121.6 | −119.7 | 0.39 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 387 / 18533 (2.1%) | 10638 / 185330 (5.7%) | −121.6 | −119.7 | 0.36 |
| RNF2 SRX18954702 | FaDu Others | 1076 / 18533 (5.8%) | 20324 / 185330 (11.0%) | −121.2 | −119.3 | 0.53 |
| LEO1 SRX15147190 | DLD-1 Digestive tract | 840 / 18533 (4.5%) | 3099 / 185330 (1.7%) | −121.2 | −119.3 | 2.71 |
| CDK9 SRX10131663 | Bronchial tracheal epithelial cells Lung | 1056 / 18533 (5.7%) | 4442 / 185330 (2.4%) | −121.1 | −119.2 | 2.38 |
| TFAP2C SRX128099 | MCF-7 Breast | 465 / 18533 (2.5%) | 11804 / 185330 (6.4%) | −120.7 | −118.9 | 0.39 |
| ESR1 SRX10365533 | MCF-7 Breast | 257 / 18533 (1.4%) | 8500 / 185330 (4.6%) | −120.7 | −118.9 | 0.30 |
| Epitope tags SRX5877912 | U2OS Bone | 2543 / 18533 (13.7%) | 38288 / 185330 (20.7%) | −120.7 | −118.9 | 0.66 |
| EP300 SRX100540 | SK-N-SH Neural | 724 / 18533 (3.9%) | 15539 / 185330 (8.4%) | −120.5 | −118.7 | 0.47 |
| FOXA1 SRX190282 | A549 Lung | 358 / 18533 (1.9%) | 10141 / 185330 (5.5%) | −120.5 | −118.6 | 0.35 |
| FOXA1 SRX6860635 | T-47D Breast | 387 / 18533 (2.1%) | 10596 / 185330 (5.7%) | −120.4 | −118.5 | 0.37 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 909 / 18533 (4.9%) | 18069 / 185330 (9.7%) | −120.4 | −118.5 | 0.50 |
| FOXA1 SRX1161205 | T-47D Breast | 276 / 18533 (1.5%) | 8806 / 185330 (4.8%) | −120.4 | −118.5 | 0.31 |
| MECOM SRX23677885 | HNT-34 Blood | 1715 / 18533 (9.3%) | 9032 / 185330 (4.9%) | −120.1 | −118.2 | 1.90 |
| STAT3 SRX150536 | MCF 10A Breast | 570 / 18533 (3.1%) | 13326 / 185330 (7.2%) | −120.0 | −118.2 | 0.43 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 853 / 18533 (4.6%) | 17292 / 185330 (9.3%) | −120.0 | −118.2 | 0.49 |
| ESR1 SRX1531796 | MCF-7 Breast | 283 / 18533 (1.5%) | 8908 / 185330 (4.8%) | −119.9 | −118.1 | 0.32 |
| SS18 SRX10881848 | G-401 Kidney | 679 / 18533 (3.7%) | 14879 / 185330 (8.0%) | −119.8 | −118.0 | 0.46 |
| ARID1A SRX5089391 | MCF-7 Breast | 300 / 18533 (1.6%) | 9179 / 185330 (5.0%) | −119.7 | −117.9 | 0.33 |
| FOXA1 SRX1161207 | T-47D Breast | 217 / 18533 (1.2%) | 7760 / 185330 (4.2%) | −119.2 | −117.3 | 0.28 |
| ESR1 SRX5323877 | MCF-7 Breast | 409 / 18533 (2.2%) | 10887 / 185330 (5.9%) | −119.1 | −117.2 | 0.38 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 299 / 18533 (1.6%) | 9138 / 185330 (4.9%) | −118.9 | −117.1 | 0.33 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 336 / 18533 (1.8%) | 9730 / 185330 (5.3%) | −118.7 | −116.9 | 0.35 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 427 / 18533 (2.3%) | 11147 / 185330 (6.0%) | −118.7 | −116.9 | 0.38 |
| MCM2 SRX12221322 | HCT 116 Digestive tract | 320 / 18533 (1.7%) | 496 / 185330 (0.3%) | −118.7 | −116.8 | 6.45 |
| FOXA3 SRX2630190 | Hep G2 Liver | 439 / 18533 (2.4%) | 11331 / 185330 (6.1%) | −118.7 | −116.8 | 0.39 |
| SFPQ SRX593748 | MCF-7 Breast | 2861 / 18533 (15.4%) | 17970 / 185330 (9.7%) | −118.6 | −116.8 | 1.59 |
| NFIL3 SRX2630334 | Hep G2 Liver | 423 / 18533 (2.3%) | 11079 / 185330 (6.0%) | −118.5 | −116.7 | 0.38 |
| FOXA1 SRX3931056 | MCF-7 Breast | 310 / 18533 (1.7%) | 9299 / 185330 (5.0%) | −118.5 | −116.6 | 0.33 |
| RXRB SRX2636027 | Hep G2 Liver | 558 / 18533 (3.0%) | 13088 / 185330 (7.1%) | −118.4 | −116.6 | 0.43 |
| HIF1A SRX8180621 | Peripheral blood mononuclear cells Blood | 186 / 18533 (1.0%) | 102 / 185330 (0.1%) | −118.2 | −116.4 | 18.24 |
| NR3C1 SRX17639413 | A549 Lung | 361 / 18533 (1.9%) | 10103 / 185330 (5.5%) | −118.1 | −116.2 | 0.36 |
| EP300 ERX626821 | U-937 Blood | 1187 / 18533 (6.4%) | 5366 / 185330 (2.9%) | −118.0 | −116.2 | 2.21 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 939 / 18533 (5.1%) | 18360 / 185330 (9.9%) | −118.0 | −116.2 | 0.51 |
| CEBPB SRX2194250 | SUM 159PT Breast | 626 / 18533 (3.4%) | 14049 / 185330 (7.6%) | −118.0 | −116.1 | 0.45 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 529 / 18533 (2.9%) | 12642 / 185330 (6.8%) | −117.9 | −116.1 | 0.42 |
| AR SRX1067068 | LHSAR Prostate | 603 / 18533 (3.3%) | 13714 / 185330 (7.4%) | −117.8 | −115.9 | 0.44 |
| ESR1 SRX20282959 | MCF-7 Breast | 229 / 18533 (1.2%) | 7922 / 185330 (4.3%) | −117.7 | −115.8 | 0.29 |
| FOXA1 SRX219284 | LNCAP Prostate | 672 / 18533 (3.6%) | 14687 / 185330 (7.9%) | −117.6 | −115.8 | 0.46 |
| Epitope tags SRX2255894 | 293 Kidney | 1325 / 18533 (7.1%) | 6318 / 185330 (3.4%) | −117.5 | −115.7 | 2.10 |
| MEN1 SRX11712604 | K-562 Blood | 1373 / 18533 (7.4%) | 6649 / 185330 (3.6%) | −117.5 | −115.7 | 2.06 |
| DAXX SRX1021630 | PC-3 Prostate | 522 / 18533 (2.8%) | 12519 / 185330 (6.8%) | −117.4 | −115.6 | 0.42 |
| FOXA2 SRX11650946 | hESC derived pancreatic cells Pluripotent stem cell | 270 / 18533 (1.5%) | 8605 / 185330 (4.6%) | −117.4 | −115.5 | 0.31 |
| KAT7 DRX300414 | 293 Kidney | 592 / 18533 (3.2%) | 1750 / 185330 (0.9%) | −117.4 | −115.5 | 3.38 |
| FOXA1 SRX3931032 | MCF-7 Breast | 309 / 18533 (1.7%) | 9245 / 185330 (5.0%) | −117.3 | −115.5 | 0.33 |
| FOXA1 SRX1447316 | MCF-7 Breast | 228 / 18533 (1.2%) | 7893 / 185330 (4.3%) | −117.3 | −115.5 | 0.29 |
| ESR1 SRX1012633 | MCF-7 Breast | 280 / 18533 (1.5%) | 8754 / 185330 (4.7%) | −116.9 | −115.0 | 0.32 |
| FOXA2 SRX11650947 | hESC derived pancreatic cells Pluripotent stem cell | 351 / 18533 (1.9%) | 9895 / 185330 (5.3%) | −116.7 | −114.9 | 0.35 |
| DLX5 SRX17306262 | Trophoblast stem cells Placenta | 618 / 18533 (3.3%) | 13880 / 185330 (7.5%) | −116.7 | −114.9 | 0.45 |
| ESR1 SRX8537723 | MCF-7 Breast | 426 / 18533 (2.3%) | 11053 / 185330 (6.0%) | −116.5 | −114.7 | 0.39 |
| FOXA1 SRX5203303 | MCF-7 Breast | 192 / 18533 (1.0%) | 7226 / 185330 (3.9%) | −116.3 | −114.5 | 0.27 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 351 / 18533 (1.9%) | 9879 / 185330 (5.3%) | −116.3 | −114.5 | 0.36 |
| KAT6A SRX20971024 | Fibroblasts Others | 140 / 18533 (0.8%) | 27 / 185330 (0.0%) | −116.1 | −114.3 | 51.85 |
| FOXA2 SRX11650943 | hESC derived pancreatic cells Pluripotent stem cell | 328 / 18533 (1.8%) | 9502 / 185330 (5.1%) | −115.9 | −114.1 | 0.35 |
| FOXA2 SRX11650945 | hESC derived pancreatic cells Pluripotent stem cell | 331 / 18533 (1.8%) | 9546 / 185330 (5.2%) | −115.9 | −114.1 | 0.35 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 733 / 18533 (4.0%) | 15463 / 185330 (8.3%) | −115.8 | −114.0 | 0.47 |
| MED1 SRX4937342 | HCT 116 Digestive tract | 1300 / 18533 (7.0%) | 6182 / 185330 (3.3%) | −115.8 | −114.0 | 2.10 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 613 / 18533 (3.3%) | 13769 / 185330 (7.4%) | −115.7 | −113.9 | 0.45 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 882 / 18533 (4.8%) | 17492 / 185330 (9.4%) | −115.6 | −113.8 | 0.50 |
| FOXA1 SRX15431000 | T-47D Breast | 428 / 18533 (2.3%) | 11029 / 185330 (6.0%) | −115.2 | −113.4 | 0.39 |
| FOSL2 SRX10475315 | Hep G2 Liver | 580 / 18533 (3.1%) | 13273 / 185330 (7.2%) | −115.2 | −113.3 | 0.44 |
| NCOA3 SRX4663589 | MCF-7 Breast | 159 / 18533 (0.9%) | 6590 / 185330 (3.6%) | −115.2 | −113.3 | 0.24 |
| FOXA1 SRX15430988 | MDA-MB-453 Breast | 530 / 18533 (2.9%) | 12551 / 185330 (6.8%) | −115.1 | −113.3 | 0.42 |
| GFP SRX6949256 | HeLa Uterus | 578 / 18533 (3.1%) | 13243 / 185330 (7.1%) | −115.1 | −113.3 | 0.44 |
Showing first 500 of 28492 rows.